Literature DB >> 12750395

CD44--a sticky target for asthma.

Marc E Rothenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12750395      PMCID： PMC155053          DOI： 10.1172/JCI18392

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

Review 1.  Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation.

Authors:  A Ray; L Cohn
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Asthma.

Authors:  W W Busse; R F Lemanske
Journal:  N Engl J Med       Date:  2001-02-01       Impact factor: 91.245

Review 3.  The germless theory of allergic disease: revisiting the hygiene hypothesis.

Authors:  M Wills-Karp; J Santeliz; C L Karp
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

Review 4.  Chemokines in asthma: cooperative interaction between chemokines and IL-13.

Authors:  Nives Zimmermann; Gurjit Khurana Hershey; Paul S Foster; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

5.  Activation and transforming growth factor-beta production in eosinophils by hyaluronan.

Authors:  Y Ohkawara; G Tamura; T Iwasaki; A Tanaka; T Kikuchi; K Shirato
Journal:  Am J Respir Cell Mol Biol       Date:  2000-10       Impact factor: 6.914

6.  A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia.

Authors:  Shigeki Katoh; Nobuhiro Matsumoto; Kumiko Kawakita; Akira Tominaga; Paul W Kincade; Shigeru Matsukura
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

7.  Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis.

Authors:  K Mikecz; F R Brennan; J H Kim; T T Glant
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

Review 8.  The role of adhesion molecules in allergic inflammation and their suitability as targets of antiallergic therapy.

Authors:  R P Schleimer; B S Bochner
Journal:  Clin Exp Allergy       Date:  1998-08       Impact factor: 5.018

9.  Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

Authors:  Christian Termeer; Frauke Benedix; Jonathon Sleeman; Christina Fieber; Ursula Voith; Thomas Ahrens; Kensuke Miyake; Marina Freudenberg; Christopher Galanos; Jan Christoph Simon
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

10.  Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7).

Authors:  B M Wittig; B Johansson; M Zöller; C Schwärzler; U Günthert
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307
View more
  6 in total

Review 1.  Origin, regulation and physiological function of intestinal oeosinophils.

Authors:  Patricia C Fulkerson; Marc E Rothenberg
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

Review 2.  Activation states of blood eosinophils in asthma.

Authors:  M W Johansson
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

Review 3.  Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Immunobiology       Date:  2014-12-31       Impact factor: 3.144

4.  Hyaluronan stimulates ex vivo B lymphocyte chemotaxis and cytokine production in a murine model of fungal allergic asthma.

Authors:  Sumit Ghosh; Scott A Hoselton; Steve B Wanjara; Jennifer Carlson; James B McCarthy; Glenn P Dorsam; Jane M Schuh
Journal:  Immunobiology       Date:  2015-02-07       Impact factor: 3.144

5.  Corticosteroid administration reduces the concentration of hyaluronan in bronchoalveolar lavage in a murine model of eosinophilic airway inflammation.

Authors:  Glenda Ernst; Silvina Lompardía; Rosalía Cordo Russo; Virginia Gentilini; Stella Venturiello; Fernando Galíndez; Pedro Grynblat; Silvia E Hajos
Journal:  Inflamm Res       Date:  2012-07-28       Impact factor: 4.575

6.  IL-13 is a driver of COVID-19 severity.

Authors:  Alexandra N Donlan; Tara E Sutherland; Chelsea Marie; Saskia Preissner; Benjamin T Bradley; Rebecca M Carpenter; Jeffrey M Sturek; Jennie Z Ma; G Brett Moreau; Jeffrey R Donowitz; Gregory A Buck; Myrna G Serrano; Stacey L Burgess; Mayuresh M Abhyankar; Cameron Mura; Philip E Bourne; Robert Preissner; Mary K Young; Genevieve R Lyons; Johanna J Loomba; Sarah J Ratcliffe; Melinda D Poulter; Amy J Mathers; Anthony J Day; Barbara J Mann; Judith E Allen; William A Petri
Journal:  JCI Insight       Date:  2021-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.